Last reviewed · How we verify

NCT05099705

Testing a Family Service Navigator Program for Low-resourced Families of Young Children with Autism Spectrum Disorder

Active, enrolled NA Last updated 12 March 2025
What this trial tests

NA trial testing Access to a Family Service Navigator and Treatment Support System in Autism Spectrum Disorder in 55 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 July 2022
Primary endpoint
30 April 2026
30 April 2026

Quick facts

Lead sponsorVanderbilt University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment55
Start date1 July 2022
Primary completion30 April 2026
Estimated completion30 April 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Vanderbilt University

Who can join

18 and older, any sex, with Autism Spectrum Disorder or Mental Health Services. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop and test a family navigator training and an app (a technology-based treatment support system) for low-resourced families of young children (aged 3-5) with autism. The hypothesis is that the navigator training and treatment support system will help enable navigators to support families of young children with autism in accessing needed services.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other Vanderbilt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05099705.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing